Affecting approximately 4%–6% of the Caucasian population, HαT is associated with mast cell-mediated symptoms, including cutaneous reactions, anaphylaxis, and functional gastrointestinal (GI) disorders. This evidence concerns the gene TMPRSS11D and anaphylaxis.